Home Newsletters Hematopoiesis News The BET Bromodomain Inhibitor ZEN-3365 Targets the Hedgehog Signaling Pathway in Acute...

The BET Bromodomain Inhibitor ZEN-3365 Targets the Hedgehog Signaling Pathway in Acute Myeloid Leukemia

0
Scientists investigated the effect of ZEN-3365, a novel BRD4 inhibitor, on acute myeloid leukemia cells in regard to the Hedgehog pathway.
[Annals of Hematology]
7992332 {7992332:WFBMRE9S} apa 50 1 165230 https://www.stemcellsciencenews.com/wp-content/plugins/zotpress/
Full Article
Exit mobile version